Biography

Dr. Mba Uzoma Mba is a board-certified endocrinologist and physician-scientist who joined Diabetes & Endocrine Specialists in 2023. He cares for adults with the full range of endocrine conditions, with particular interest in thyroid disease, osteoporosis and adrenal disorders.

He earned his combined MD and PhD at Virginia Commonwealth University School of Medicine and the Scripps Research Institute, where his doctoral research investigated non-invasive molecular biomarkers of chronic kidney transplant dysfunction. Before medical school he studied chemistry at Duke University and earned a master’s degree in pharmacology at Virginia Commonwealth University. He completed his internal medicine residency in the research program at Scripps Green Hospital and his fellowship in endocrinology, diabetes and metabolism at Scripps Clinic in San Diego, including a year as a clinical scholar at the Scripps Research Translational Institute. He is board-certified in internal medicine and has been board-certified in endocrinology, diabetes and metabolism since 2024.

Dr. Mba approaches each patient with thoroughness and a commitment to translating complex endocrine physiology into clear, practical guidance.

---

Research & presentations

His research spans clinical trials in sepsis at Duke University, neuropharmacology and transplant genomics at Virginia Commonwealth University, and clinical endocrinology. He is a co-investigator on the practice’s thyroid radiofrequency ablation outcomes study, presented at ENDO 2026, and has presented at the annual meeting of the American Thyroid Association. Thyroid RFA outcomes

Selected publications & presentations

• Schneider DA, Mba UM, Vizcarra Osuna J. Single-session trans-isthmic radiofrequency ablation for benign thyroid nodules: six-month outcomes from 118 consecutive patients in a U.S. community endocrine practice. ENDO 2026, Chicago.
• Mba MU, Gadre G, McGarvey M. RAIsing porphyria: a curious reaction to radioactive iodine. Poster, 89th Annual Meeting of the American Thyroid Association, Chicago.
• Shultz JC, et al. (incl. Mba MU). The proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA. Mol Cancer Res. 2012;10(5):660–669.
• Scian MJ, et al. (incl. Mba MU). MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant. 2011;11(10):2110–2122.
• Sim-Selley LJ, et al. (incl. Mba MU). Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS. J Neurochem. 2009;110(4):1191–1202.
• Moretti EW, et al. (incl. Mba MU). APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med. 2005;33(11):2521–2526.

Training & Education

• BS, Chemistry — Duke University
• MS, Pharmacology — Virginia Commonwealth University
• MD/PhD — Virginia Commonwealth University School of Medicine and the Scripps Research Institute
• Internal medicine residency (research program) — Scripps Green Hospital, San Diego
• Fellowship, Endocrinology, Diabetes & Metabolism — Scripps Clinic, San Diego
• Clinical scholar — Scripps Research Translational Institute

Honors

• Robert A. Ramsey Award for outstanding doctoral student, VCU Department of Physiology & Biophysics
• American Physician Scientists Association National Conference Travel Award
• Phi Kappa Phi Honor Society

Clinical Interests

• Thyroid disease, including thyroid nodules and hyperthyroidism
• Osteoporosis and metabolic bone disease
• Adrenal disorders
• Diabetes and general endocrinology